Genentech Inc.

Headquarters location: 1 DNA Way South San Francisco, CA 94080-4990 Tel. 650-225-1000 Job offers, investor relations: www.gene.com Email: investor.relations@gene.com Stock:

Genentech belongs to shareholder country     % source Bank of America Corp. 3.4 Barclays Plc 2.5 Capital Research & Management Inc. 0.8 Citigroup Inc. 1.9 FMR Corp. (Fidelity Investments) 4.5 Janus Capital Corp. 2.3 Roche Holding 56 TCW Group 3 Wellington Management Co. 0.9	Brands name items photo compare the prices Genentech Ethishop Tanox Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF GENENTECH , group Roche Holding and subsidiaries [click on the images below or on help for more information] 4% Job: 4% of company's jobs cut since 1998 2 Environment: 2 major pollution(s) 5 Delinquency: 5 act(s) of financial or trade delinquency 2 Tax haven, secret bank account, shell companies: operates in 2 offshore financial center(s) 31 Sales: more than 31 billion(s) dollars/euros in annual sales 15 Net profit: more than 15 billion(s) dollars/euros in cumulated net profit since 1998 505 Top management: earns 505 times the median income in the United States (32000 US$/year) 10 Influence: 10 act(s) of direct corruption or lobbying 1 Advertising & marketing: 1 dubious practice(s) Full profile >>>
Relevance: business & market share year business source 2004 The world's second largest biotechnology group. Les Echos Genentech is managed by year name photo position; compensation source 2003Hellman, Susan Chairman; 2003Juelsgaard, Stephen Vice-president; 2003Lavigne Jr, Louis Chief Financial Officer; salary: 0.81 million US$; stock-options: 14.27 million US$; 2003Potter, Myrtle Chairman; salary: 1.74 million US$; stock-options: 7.8 million US$; 1999Humer, F B Director; 1998Levinson, Arthur D Chief Executive Officer; salary: 1.08 million US$; Forbes Highest paid executives in 2007

Made by year employees <> social impact : country source 2003 6226 2002 5252 1998 3389 Layoff plans and labour conditions in 2007 Influence year purpose : intermediary/lobby : institution source 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. 1998 Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 97 thousand US$ : US President, Congress, Senate translate Center for. Influence in 2007 Financials year   sales income buyback source 2007   2 billion US$ 2005   4 billion US$ The Street. 2004   4.6   billion US$ 2003   2.8 0.56   billion US$ 2002   2.25 0.06   billion US$ 2001   1.82 0.15   billion US$ 2000   1.65 -0.02   billion US$ 1998   1.06 0.18   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Banco internacional investimentos   No Tax Haven - Saturday 21 June 2008 at 13h02

Banco internacional investimentos   Another offshore bank? - Saturday 21 June 2008 at 13h00

Banco internacional investimentos   Sustainable Bank - Saturday 21 June 2008 at 12h54

Amerada hess   Reverend - Thursday 19 June 2008 at 08h17

Anshan benxi steel group   Sgt. - Thursday 19 June 2008 at 02h04

All comments